GE HealthCare Technologies (GEHC) Receivables - Other (2022 - 2026)

GE HealthCare Technologies' Receivables - Other history runs 5 years deep, the most recent figure standing at $715.0 million for Q1 2026.

• Quarterly Receivables - Other rose 25.0% year-over-year to $715.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $715.0 million (up 25.0% YoY) and the FY2025 annual result came in at $645.0 million, up 9.51% from the prior year.
• Receivables - Other was $715.0 million for Q1 2026 at GE HealthCare Technologies, up from $339.0 million in the prior quarter.
• Across five years, Receivables - Other topped out at $715.0 million in Q1 2026 and bottomed at $284.0 million in Q4 2023.
• A 5-year average of $565.4 million and a median of $602.0 million in 2023 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2023 — Receivables - Other tumbled 51.37% — and 2026, when it climbed 25.0%.
• GE HealthCare Technologies' Receivables - Other stood at $584.0 million in 2022, then tumbled by 51.37% to $284.0 million in 2023, then increased by 1.06% to $287.0 million in 2024, then grew by 18.12% to $339.0 million in 2025, then soared by 110.91% to $715.0 million in 2026.
• Business Quant data shows GEHC's Receivables - Other at $715.0 million in Q1 2026, $339.0 million in Q4 2025, and $708.0 million in Q3 2025.